Skip to main content

Table 1 Patients' characteristics.

From: Efficacy of repeated intrathecal triamcinolone acetonide application in progressive multiple sclerosis patients with spinal symptoms

Age

50.10 ± 10.30, 21 – 78 years

Duration of MS

14.32 ± 7.63, 2 – 40 years

Sex

119 men, 42 women

MS types

chronic progressive: n = 35

 

secondary progressive: n = 122

 

relapsing-remitting: n = 4

Length of hospital stay

28.41 ± 5.97; 21 – 60 days

Back to article page

BMC Neurology

ISSN: 1471-2377

Contact us